Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyBCTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyBCTeam Member asked a question 💭
Greenville, SC
April 27
 · 
Be the first to react
HER2-Positive Breast Cancer: Prognosis and Survival Rates Read Article...
MyBCTeam

It sounds like you're asking about what it means to be HER2-negative and estrogen receptor-positive (ER+). This is actually one of the most common breast cancer subtypes, so you're definitely not alone in navigating this.

Here's what those results mean:

- HER2-negative means your cancer cells do not overproduce the HER2 Show Full Answer

It sounds like you're asking about what it means to be HER2-negative and estrogen receptor-positive (ER+). This is actually one of the most common breast cancer subtypes, so you're definitely not alone in navigating this.

Here's what those results mean:

- HER2-negative means your cancer cells do not overproduce the HER2 protein, so targeted HER2 therapies (like trastuzumab) are not part of your treatment plan
- ER-positive (ER+) means your cancer cells have estrogen receptors, and estrogen is helping the cancer grow

Because your cancer is fueled by estrogen, hormone therapy is typically a key part of treatment. This may include:

- Tamoxifen – blocks estrogen from attaching to cancer cells
- Aromatase inhibitors – reduce the amount of estrogen in your body

The good news is that ER+ breast cancer often responds very well to hormone therapy, and outcomes are generally favorable, especially when caught early.

That said, every situation is unique, so it's always best to talk with your oncologist about the treatment plan that's right for you specifically.

April 27

Related Questions

View All